drugset / Trial / NCT03217409

A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia

NCT03217409

Phase 4 Completed 85 enrolled Yuhan Corporation Linical Korea · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

A Study to Compare Rosuvastatin/Ezetimibe Combination and Monotherapy in Patients with Diabetes Mellitus and Hypercholesterolemia.

Timeline

Start
2017-08-10
Primary completion
2019-04-03
Completion
2019-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg
Subject Rosuvastatin Small molecule 5 mg

Indications